Subcutaneous injection is considered a standard method for the delivery of medication into a patient’s body. To facilitate subcutaneous injection, subcutaneous injection ports are used. Subcutaneous injection ports are sterile medication delivery device. Subcutaneous injection ports consists of a silicone injection membrane on a hard base. Through subcutaneous injection port physician prescribed medications can be directly injected into the subcutaneous tissue using a standard needle and syringe, an injection pen, or other manual injection device. Subcutaneous injection port is a device that cannot be used with an injection pump. Furthermore, subcutaneous injection ports are also used for multiple subcutaneous injections for a period of up to 72 hours. Subcutaneous injection port avoids the repeated needle punctures of the skin. This device is widely used for patients who require prolonged central venous access. A subcutaneous injection port is generally a disposable device usually inserted into the skin for a period of up to 5 days. Insulin is injected through a syringe into subcutaneous injection port. Medicines are directly injected through the resealable septum at the top of the device. The needle of the syringe is placed above the surface of the skin whereas the medication is delivered through the soft cannula. A subcutaneous injection port consists of a build in inserter, which give users a virtually painless application. A subcutaneous injection port is usually used with an intrathecal or epidural catheter. Subcutaneous injection ports have low infection rate, but require suitable expertise for their insertion.
The global subcutaneous injection ports market is expected to witness a significant growth over the forecast period due to rising prevalence of cancer and diabetes across the globe. Increasing investment of manufacturers in the development of subcutaneous injection port is further driving the growth of the global subcutaneous injection ports market. Furthermore, over the past decade, more patient-friendly devices have enhanced the demand for subcutaneous injection ports. However, lack of focus on health expenditure, declining reimbursements and others factors are the hindrance of the global subcutaneous injection ports market.
Get Experts’ Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=876
On the basis of geography, the global subcutaneous injection ports market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and the Middle East & Africa. North America will continue to dominate the global subcutaneous injection ports market due to the availability of advanced technologies. Europe is expected to hold the second large market share in the global subcutaneous injection ports market. Asia Pacific is also one of the fast-growing regions in the global subcutaneous injection ports market due to high incidence of diabetes in low-income countries. Moreover, the Middle East and Africa and Latin America are expected to show slow growth in the global subcutaneous injection ports market due to delayed introduction of the product in these regions.
Examples of some of the key players present in the global subcutaneous injection ports market are Medtronic MiniMed, Inc., Applied Medical Technology Ltd, Unomedical a/s and others.
Your information will never be shared with any third party.